Pfizer Inc.
COMPOUNDS AND USES THEREOF TO TREAT TUMORS IN A SUBJECT
Last updated:
Abstract:
The present invention relates to compounds that can be used to induce immunogenic cell death (ICD). In some instances, two or more compounds are combined to induce ICD. The invention also relates to the combination of ICD-inducing compounds with an agent stimulating the immune system, such as an immune checkpoint inhibitor, in particular, to 5 treat cancer or inhibit tumor growth.
Status:
Application
Type:
Utility
Filling date:
13 Mar 2019
Issue date:
18 Nov 2021